Dylan Verden
Chief Science Officer KIF1A.ORG
Seminars
Thursday 21st May 2026
Reimagining Rare Disease Treatment Through Intranasal Delivery to Transform Patient Experience
10:00 am
- Human Impact of Rare Disease: Framing unmet needs through the lived experience of patients and families
- Why Nasal Delivery Changes the Paradigm: Lessons from neurology showing how intranasal routes can replace invasive administration
- ASOs and the Nose-to-Brain Opportunity: Exploring why intranasal delivery may unlock safer, more practical CNS access
